Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis

OBJECTIVES: To investigate the possible role of baseline plasma tumour necrosis factor alpha levels (baseline-TNF) on the clinical response to infliximab in patients with rheumatoid arthritis (RA). METHODS: Patients with RA refractory to methotrexate received 3, 6, or 10 mg/kg of infliximab every 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Tatsuki, Yoshihiko, Yano, Toshiro, Yoshinari, Toru, Abe, Tohru, Koike, Takao
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103666/
https://www.ncbi.nlm.nih.gov/pubmed/21478189
http://dx.doi.org/10.1136/ard.2011.153023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103666/
https://www.ncbi.nlm.nih.gov/pubmed/21478189
http://dx.doi.org/10.1136/ard.2011.153023

Ejemplares similares